Myron S. Czuczman
2021
In 2021, Myron S. Czuczman earned a total compensation of $724.5K as Chief Medical Officer and Executive Vice President at Citius Pharmaceuticals, a 358% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $148,750 |
---|---|
Option Awards | $174,857 |
Salary | $400,000 |
Other | $917 |
Total | $724,524 |
Czuczman received $400K in salary, accounting for 55% of the total pay in 2021.
Czuczman also received $148.8K in non-equity incentive plan, $174.9K in option awards and $917 in other compensation.
Rankings
In 2021, Myron S. Czuczman's compensation ranked 9,793rd out of 12,405 executives tracked by ExecPay. In other words, Czuczman earned more than 21.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,793 | 21st |
Manufacturing | 4,332 | 21st |
Chemicals And Allied Products | 1,926 | 19th |
Drugs | 1,710 | 18th |
Pharmaceutical Preparations | 1,269 | 17th |
Czuczman's colleagues
We found three more compensation records of executives who worked with Myron S. Czuczman at Citius Pharmaceuticals in 2021.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020